CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Effect of Capecitabine plus Oxaliplatin for Advanced Adenocarcinoma of Ampulla of Vater

Jung Hwan Lee, Kyung Hee Kim, Sang Myung Woo, Sang-Jae Park, Sung-Sik Han, Eun Kyung Hong, Young Hwan Koh, Ju Hee Lee, Woo Jin Lee

Korean J Pancreas Biliary Tract. 2017;22(3):127-133. Published online 2017 July 27 DOI: https://doi.org/10.15279/kpba.2017.22.3.127

Effect of Capecitabine plus Oxaliplatin for Advanced Adenocarcinoma of Ampulla of Vater

Jung Hwan Lee, Kyung Hee Kim, Sang Myung Woo, Sang-Jae Park, Sung-Sik Han, Eun Kyung Hong, Young Hwan Koh, Ju Hee Lee, Woo Jin Lee

Korean Journal of Pancreas and Biliary Tract. 2017;22(3):127-133

Link1

Link2 Link3

Coadministration of proton pump inhibitors and the efficacy of capecitabine in patients with advanced adenocarcinoma of the small bowel or ampulla of vater

Kadri Altundag

Cancer. 2017;123(6):1074-1074

Link1 Link2 Link3 Link4

735 POSTER Randomized comparison of capecitabine plus oxaliplatin (CapOx) versus capecitabine plus gemcitabine (CapGem) versus gemcitabine plus oxaliplatin (GemOx) in advanced pancreatic cancer

European Journal of Cancer Supplements. 2005;3(2):209

Link1 Link2

Capecitabine plus oxaliplatin vs fluorouracil plus oxaliplatin as first line treatment for metastatic colorectal caner â meta-analysis of six randomized trials

Y. Cao, C. Liao, A. Tan, L. Liu, Z. Mo, F. Gao

Colorectal Disease. 2010;12(1):16-23

Link1 Link2

Bevacizumab combined with capecitabine and oxaliplatin in patients with advanced adenocarcinoma of the small bowel or ampulla of vater: A single‐center, open‐label, phase 2 study

Pat Gulhati, Kanwal Raghav, Rachna T. Shroff, Gauri R. Varadhachary, Scott Kopetz, Milind Javle, Wei Qiao, Huamin Wang, Jeffrey Morris, Robert A. Wolff, Michael J. Overman

Cancer. 2016;123(6):1011-1017

Link1 Link2 Link3 Link4

PCN22 ECONOMIC ANALYSIS OF CAPECITABINE PLUS OXALIPLATIN (XELOX) VERSUS FLUOROURACIL/LEUCOVORIN PLUS OXALIPLATIN (FOLFOX) IN THE TREATMENT OF ADVANCED GASTRIC CANCER IN CHINA

W Chen

Value in Health. 2010;13(7):A514

Link1 Link2

PCN66 ECONOMIC ANALYSIS OF CAPECITABINE PLUS OXALIPLATIN (XELOX) VERSUS FLUOROURACIL/LEUCOVORIN PLUS OXALIPLATIN (FOLFOX) IN THE TREATMENT OF ADVANCED COLON-RECTUM CANCER IN CHINA

W Chen

Value in Health. 2010;13(7):A263

Link1 Link2

Comparing Capecitabine Plus Oxaliplatin Versus Capecitabine Plus Oxaliplatin With Concurrent Capecitabine Radiation Therapy in Completely Resected Gastric Cancer

L.Y. Zhang, Y.Y. Wu, J.J. Qian, L.S. Chen, Y. Tian

International Journal of Radiation Oncology*Biology*Physics. 2012;84(3):S316

Link1 Link2

Efficacy and Safety of Docetaxel Plus Oxaliplatin and Capecitabine in the First Line Treatment of Advanced Gastric Adenocarcinoma

Ying Liu, Zhengbao Ye, Wenqi Xi, Tao Ma, Min Shi, Liu Yang, Zhenggang Zhu, Jun Zhang

BioMed Research International. 2013;2013:1-6

Link1

Link2 Link3

Capecitabine Plus Oxaliplatin Versus Capecitabine Plus Oxaliplatin with Concurrent Radiation Therapy in the Treatment of Gastric Cancer after D2 Gastrectomy

C. Xie, D. Chen, X. Jin

International Journal of Radiation Oncology*Biology*Physics. 2018;102(3):S28-S29

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Korean J Pancreas Biliary Tract has participated in CrossRef Text and Data Mining service since October 29, 2014.